387 related articles for article (PubMed ID: 26813506)
1. [Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
Iwashita Y; Iwashita Y; Ito T; Shigematsu T
Clin Calcium; 2016 Feb; 26(2):259-67. PubMed ID: 26813506
[TBL] [Abstract][Full Text] [Related]
2. Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children.
Wesseling-Perry K; Salusky IB
Pediatr Nephrol; 2013 Apr; 28(4):617-25. PubMed ID: 23381010
[TBL] [Abstract][Full Text] [Related]
3. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993
[TBL] [Abstract][Full Text] [Related]
4. Osteo-renal regulation of systemic phosphate metabolism.
Razzaque MS
IUBMB Life; 2011 Apr; 63(4):240-7. PubMed ID: 21438115
[TBL] [Abstract][Full Text] [Related]
5. [Chronic kidney disease (CKD) and bone. The mechanisms of chronic kidney disease--mineral and bone disorder (CKD-MBD)].
Hamada Y; Fukagawa M
Clin Calcium; 2009 Apr; 19(4):486-92. PubMed ID: 19329826
[TBL] [Abstract][Full Text] [Related]
6. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality].
Taniguchi M
Clin Calcium; 2010 Jul; 20(7):1078-87. PubMed ID: 20585187
[TBL] [Abstract][Full Text] [Related]
7. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD].
Koiwa F; Maruta Y
Clin Calcium; 2010 Jul; 20(7):1089-95. PubMed ID: 20585188
[TBL] [Abstract][Full Text] [Related]
8. Impact of Cinacalcet and Etelcalcetide on Bone Mineral and Cardiovascular Disease in Dialysis Patients.
Bernardor J; De Mul A; Bacchetta J; Schmitt CP
Curr Osteoporos Rep; 2023 Apr; 21(2):193-204. PubMed ID: 36848027
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease and fragility fracture.
Kazama JJ
Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):46-52. PubMed ID: 28012057
[TBL] [Abstract][Full Text] [Related]
10. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
Bover J; Ureña-Torres P; Lloret MJ; Ruiz C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
Expert Opin Pharmacother; 2016 Jul; 17(10):1363-73. PubMed ID: 27156578
[TBL] [Abstract][Full Text] [Related]
11. CKD-MBD: impact on management of kidney disease.
Ogata H; Koiwa F; Kinugasa E; Akizawa T
Clin Exp Nephrol; 2007 Dec; 11(4):261-268. PubMed ID: 18085385
[TBL] [Abstract][Full Text] [Related]
12. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone metabolism in CKD-MBD].
Kazama JJ
Clin Calcium; 2010 Jul; 20(7):1038-44. PubMed ID: 20585182
[TBL] [Abstract][Full Text] [Related]
13. Research on kidney and mineral metabolism in Japan: past, present, and future.
Mizobuchi M; Ogata H; Koiwa F; Kinugasa E; Akizawa T
Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):4-8. PubMed ID: 28005175
[TBL] [Abstract][Full Text] [Related]
14. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
[TBL] [Abstract][Full Text] [Related]
15. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
16. Cinacalcet versus standard treatment for chronic kidney disease: a systematic review and meta-analysis.
Sekercioglu N; Busse JW; Sekercioglu MF; Agarwal A; Shaikh S; Lopes LC; Mustafa RA; Guyatt GH; Thabane L
Ren Fail; 2016 Jul; 38(6):857-74. PubMed ID: 27137817
[TBL] [Abstract][Full Text] [Related]
17. Mineral metabolism and cardiovascular disease in CKD.
Fujii H; Joki N
Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938
[TBL] [Abstract][Full Text] [Related]
18. [Chronic kidney disease--mineral and bone disorder: why and how to control phosphate].
Pavlović D; Katicić D; Josipović J
Acta Med Croatica; 2012 Oct; 66 Suppl 2():64-7. PubMed ID: 23513419
[TBL] [Abstract][Full Text] [Related]
19. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Parathyroid interventions: final one piece in the management of uremic SHPT patients].
Uemura K; Kakuta T
Clin Calcium; 2010 Jul; 20(7):1104-10. PubMed ID: 20585190
[TBL] [Abstract][Full Text] [Related]
20. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Paradigm shift in CKD-MBD guideline].
Yokoyama K
Clin Calcium; 2010 Jul; 20(7):1012-20. PubMed ID: 20585179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
